FDA.reportPublic FDA data

nintedanib Oral Capsule [Ofev]

RxCUI
1592745
RxNorm name
nintedanib Oral Capsule [Ofev]
Term type
SBDF
Status
Active
Updated
2026-10-15 15:43:58

RxNorm Status History#

Status
Active
Source
RXNORM
Current
YES
Release start
122014
Active start
122014
Multiple ingredient
NO
Branded
YES

Dose Form Concepts#

Dose form, RxCUI table
Dose formRxCUI
Oral Capsule316965

Derived Ingredient Concepts#

Ingredient, RxCUI table
IngredientRxCUI
nintedanib1592737

Source Vocabulary Codes#

Code type, Values, Count table
Code typeValuesCountCategory
PRESCRIBABLEY1ATTRIBUTES
RXNAV_STRnintedanib Oral Capsule [Ofev]1NAMES
RxNorm Namenintedanib Oral Capsule [Ofev]1NAMES
TTYSBDF1ATTRIBUTES
RxCUI15927451CODES

RxNav Current And Historical NDCs#

RxNav current and historical NDC rows page 1 of 1 · 0 matching rows.

No records found.

UNII Substances#

UNII substance links page 1 of 1 · 0 matching rows.

No records found.

Reported adverse events (FAERS/openFDA)#

Adverse event summaries are temporarily unavailable. Other product information remains available.

DailyMed RxNorm Mappings#

unique DailyMed labels mapped to this RxNorm concept page 1 of 1 · 0 matching rows.

No records found.

Drug Classes#

Source, Class ID, Class table
SourceClass IDClassTypeRelationshipDrug concept
ATCL01EXOther protein kinase inhibitorsATC1-4nintedanib
FDASPLN0000175605Kinase InhibitorEPChas_epcnintedanib
FDASPLN0000175076Protein Kinase InhibitorsMOAhas_moanintedanib
MEDRTD007211IndolesCHEMhas_ingredientnintedanib
MEDRTD054990Idiopathic Pulmonary FibrosisDISEASEmay_treatnintedanib
MEDRTN0000020000Receptor Tyrosine Kinase InhibitorsMOAhas_moanintedanib
MEDRTN0000175678Decreased Endothelial ProliferationPEhas_penintedanib

Properties#

Category, Property, Value table
CategoryPropertyValue
ATTRIBUTESGENERAL_CARDINALITYSINGLE
ATTRIBUTESRXNAV_HUMAN_DRUGUS